Survey of 400 senior finance leaders reveals the growing impact of late payments and cash flow uncertainty on strategic decision-making SAN FRANCISCO, Feb. 2, 2026Survey of 400 senior finance leaders reveals the growing impact of late payments and cash flow uncertainty on strategic decision-making SAN FRANCISCO, Feb. 2, 2026

Versapay Releases 2026 Cash Flow Clarity Report: CFOs Face Rising Cash Flow Uncertainty Amid Persistent Payment Delays

2026/02/02 20:46

Survey of 400 senior finance leaders reveals the growing impact of late payments and cash flow uncertainty on strategic decision-making

SAN FRANCISCO, Feb. 2, 2026 /PRNewswire/ — Versapay has released the 2026 Annual Cash Flow Clarity Report, developed in partnership with Wakefield Research, at a time when finance leaders are under growing pressure to do more with less amid economic uncertainty, rising costs, and tighter access to capital. Based on a survey of 400 finance leaders in the United States and Canada, the report examines how rising payment delays and increasing accounts receivable (AR) complexity are undermining cash flow predictability and why challenges once viewed as operational are now influencing core financial planning and strategic decision-making.

In the report, 69% of finance leaders report that late customer payments increased over the past 12 months, while 78% say unexpected AR issues are forcing changes to capital investments, hiring plans, and borrowing decisions. Together, these findings show that payment delays are no longer a back-office inconvenience—they’re directly constraining growth and flexibility. When cash inflows become unpredictable, finance leaders are forced to delay investments, slow hiring, or take on additional financing, weakening resilience, and competitiveness. As a result, short-term AR volatility is now shaping decisions traditionally guided by long-term forecasting and capital planning.

Key findings highlight the growing scale and operational impact of AR disruption:

  • More than two-thirds (69%) of finance leaders report an increase in late customer payments over the past year, signaling a widespread deterioration in payment reliability.
  • Nearly eight in 10 (78%) say unexpected AR issues are now forcing changes to capital investments, hiring plans, and borrowing decisions, evidence that cash flow volatility is influencing core business strategy.
  • Over four in five (81%) say collecting outstanding invoices has become more challenging, while three-quarters (74%) report their teams spend significant or moderate time each week chasing late payments, underscoring the growing operational burden on finance teams.

“Cash flow uncertainty is no longer episodic; it’s becoming a defining challenge for finance teams,” said Carey Kolaja, CEO at Versapay. “This year’s data aligns with what we hear from customers: breakdowns across the AR process create friction at every stage of the receivables cycle, compounding uncertainty and cost.”

As AR volatility disrupts cash flow and planning, finance leaders are increasingly turning to automation to restore predictability and control. In the survey, 63% of respondents report that AR automation has already reduced payment delays. Looking ahead, 91% expect automation to reduce days sales outstanding (DSO) by four or more days within the next year, with nearly one-third (29%) anticipating reductions of 11 days or more, demonstrating that automation is viewed not just as an efficiency gain, but as a meaningful lever for reducing risk and stabilizing cash flow.

Adoption plans include AI and predictive capabilities. Fifty percent of finance leaders expect to use AI to automate repetitive AR tasks, and more than one-third plan to adopt predictive analytics to identify payment risks earlier and improve collections prioritization. In total, 82% plan to increase investment in AR automation in the next 12 months.

Methodology

Wakefield Research surveyed 400 finance leaders in the United States and Canada with a minimum seniority of director, reporting to the office of the CFO, November 21st and December 3rd, 2025, using an email invitation and online survey. 

Download the report

The 2026 Cash Flow Clarity Report is available now at www.versapay.com/state-of-accounts-receivable-automation.

About Versapay 

Versapay is the platform that rewires AR by removing barriers from collecting and reconciling B2B payments, providing end-to-end cash flow clarity, ensuring businesses can manage working capital on their terms. By closing the loop for finance teams and their business systems, customers, and payment activity into a single intelligent ecosystem, Versapay transforms money matters into a data-driven advantage. With 10,000 customers and 5M+ companies transacting, Versapay facilitates 110M+ transactions and processes $260B+ in payments volume annually. To learn more about how Versapay eliminates financial friction, visit: versapay.com.

Contact:

Sarah Crowder

Media Liaison

775-232-1818

[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/versapay-releases-2026-cash-flow-clarity-report-cfos-face-rising-cash-flow-uncertainty-amid-persistent-payment-delays-302675514.html

SOURCE Versapay

면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, [email protected]으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

추천 콘텐츠

$5,000 Invested in Ripple (XRP) 10 Years Ago Is Worth Millions Today, But This Coin Will do it in a Year

$5,000 Invested in Ripple (XRP) 10 Years Ago Is Worth Millions Today, But This Coin Will do it in a Year

Ripple (XRP) has demonstrated the enormous growth ability of cryptocurrencies, as a 10-year-old investment of $5,000 now costs millions.
공유하기
The Cryptonomist2025/09/19 20:09
OFAC Designates Two Iranian Finance Facilitators For Crypto Shadow Banking

OFAC Designates Two Iranian Finance Facilitators For Crypto Shadow Banking

The Department of the Treasury’s Office of Foreign Assets Control (OFAC) sanctioned two Iranian financial facilitators for coordinating over $100 million worth of cryptocurrency in oil sales for the Iranian government, a September 16 press release shows. OFAC Sanctions Iranian Nationals According to the Tuesday press release, Iranian nationals Alireza Derakhshan and Arash Estaki Alivand “used a network of front companies in multiple foreign jurisdictions” to transfer the digital assets. OFAC alleges that Alivand and Derakhshan’s transfers also involved the sale of Iranian oil that benefited Iran’s Islamic Revolutionary Guard Corps-Qods Force (IRGC-QF) and the Ministry of Defense and Armed Forces Logistics (MODAFL). IRGC-QF and MODAFL then used the proceeds to support regional proxy terrorist organizations and strengthen their advanced weapons systems, including ballistic missiles. U.S. officials say the move targets shadow banking in the region, where illicit financial actors use overseas money laundering and digital assets to evade sanctions. “Iranian entities rely on shadow banking networks to evade sanctions and move millions through the international financial system,” said Under Secretary of the Treasury for Terrorism and Financial Intelligence John K. Hurley. “Under President Trump’s leadership, we will continue to disrupt these key financial streams that fund Iran’s weapons programs and malign activities in the Middle East and beyond,” he continued. Dozens Designated In Shadow Banking Scandal Both Alivand and Derakhshan have been designated “for having materially assisted, sponsored, or provided financial, material, or technological support for, or goods or services to or in support of the IRGC-QF.” In addition to Alivand and Derakhshan, OFAC has sanctioned more than a dozen Hong Kong and United Arab Emirates-based entities and individuals tied to the network. According to the press release, the sanctioned entities may face civil or criminal penalties imposed as a result
공유하기
CryptoNews2025/09/18 11:18
TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma

TuHURA Biosciences received FDA Orphan Drug Designation for IFx-2.0 for the Treatment of Stage IIB to Stage IV Cutaneous Melanoma

TAMPA, Fla., Feb. 2, 2026 /PRNewswire/ — TuHURA Biosciences, Inc. (NASDAQ:HURA) (“TuHURA” or the “Company”), a Phase 3 immuno-oncology company developing novel
공유하기
AI Journal2026/02/02 21:15